Antiviral agents in influenza--summary of Influenza Workshop VIII.
D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D007369:Interferon Inducers / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D011014:Pneumonia / Q000188:drug therapy; D011024:Pneumonia, Viral / Q000188:drug therapy; D012254:Ribavirin / Q000627:therapeutic use; D013729:Terpenes / Q000627:therapeutic use; D014611:Vaccination; D014762:Viral Interference
D000998:Antiviral Agents; D007369:Interferon Inducers; D013729:Terpenes; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine; D009439:Neuraminidase